piperazine has been researched along with Carcinoma, Pancreatic Ductal in 1 studies
Carcinoma, Pancreatic Ductal: Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akl, L | 1 |
| Abd El-Hafeez, AA | 1 |
| Ibrahim, TM | 1 |
| Salem, R | 1 |
| Marzouk, HMM | 1 |
| El-Domany, RA | 1 |
| Ghosh, P | 1 |
| Eldehna, WM | 1 |
| Abou-Seri, SM | 1 |
1 other study available for piperazine and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Identification of novel piperazine-tethered phthalazines as selective CDK1 inhibitors endowed with in vitro anticancer activity toward the pancreatic cancer.
Topics: Antineoplastic Agents; Carcinoma, Pancreatic Ductal; CDC2 Protein Kinase; Cell Line, Tumor; Cell Pro | 2022 |